Plasma biomarker analysis of ramucirumab in Japanese patients with advanced gastric cancer.

被引：2
|
作者：
Takahari, Daisuke [1 ]
Wakatsuki, Takeru [1 ]
Mashima, Tetsuo [1 ]
Chin, Keisho [1 ]
Ichimura, Takashi [1 ]
Ogura, Mariko [1 ]
Matsushima, Tomohiro [1 ]
Osumi, Hiroki [1 ]
Nakayama, Izuma [1 ]
Ota, Yumiko [1 ]
Shinozaki, Eiji [1 ]
Suenaga, Mitsukuni [1 ]
Kawata, Naomi [1 ]
Horiike, Yuki [1 ]
Seimiya, Hiroyuki [1 ]
Fujita, Naoya [1 ]
Yamaguchi, Kensei [1 ]
机构：
[1] Japanese Fdn Canc Res, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.81
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
81
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Plasma biomarker analysis of ramucirumab in Japanese patients with advanced gastric cancer: Preliminary results.
    Takahari, Daisuke
    Wakatsuki, Takeru
    Mashima, Tetsuo
    Ichimura, Takashi
    Chin, Keisho
    Ogura, Mariko
    Nakayama, Izuma
    Matsushima, Tomohiro
    Osumi, Hiroki
    Ozaka, Masato
    Suenaga, Mitsukuni
    Shinozaki, Eiji
    Seimiya, Hiroyuki
    Fujita, Naoya
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [2] Plasma biomarker dynamics following ramucirumab treatment and survival analysis after ramucirumab treatment failure in patients with advanced gastric cancer.
    Ota, Yumiko
    Wakatsuki, Takeru
    Mashima, Tetsuo
    Takahari, Daisuke
    Chin, Keisho
    Ichimura, Takashi
    Ogura, Mariko
    Matsushima, Tomohiro
    Osumi, Hiroki
    Nakayama, Izuma
    Shinozaki, Eiji
    Suenaga, Mitsukuni
    Kawata, Naomi
    Horiike, Yuki
    Seimiya, Hiroyuki
    Fujita, Naoya
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [3] Retrospective study of ramucirumab in patients with advanced gastric cancer.
    Sakai, Daisuke
    Kudo, Toshihiro
    Kato, Aya
    Tanaka, Koji
    Miyazaki, Yasuhiro
    Makino, Tomoki
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Yamasaki, Makoto
    Takiguchi, Shuji
    Mori, Masaki
    Doki, Yuichiro
    Satoh, Taroh
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [4] Evaluation of the safety of ramucirumab in Japanese patients with advanced gastric cancer
    Iwai, M.
    Ito, D.
    Asano, H.
    Adachi, S.
    Okada, K.
    Kimura, M.
    Usami, E.
    Matsuo, K.
    Yoshimura, T.
    Teramachi, H.
    PHARMAZIE, 2018, 73 (05): : 309 - 312
  • [5] Efficacy and safety of paclitaxel/ramucirumab as the second-line chemotherapy in Japanese patients with advanced gastric cancer.
    Kusumoto, Tetsuya
    Egashira, Akinori
    Sonoda, Hideto
    Hashimoto, Kenkichi
    Uehara, Hideo
    Kusumoto, Eiji
    Shinzato, Chiaki
    Uchino, Keita
    Sakaguchi, Yoshihisa
    Ikejiri, Koji
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Analysis of predictive factors of ramucirumab plus paclitaxel for advanced gastric cancer.
    Fukuda, Naoki
    Takahari, Daisuke
    Osumi, Hiroki
    Matsushima, Tomohiro
    Nakayama, Izuma
    Wakatsuki, Takeru
    Ogura, Mariko
    Ichimura, Takashi
    Ozaka, Masato
    Suenaga, Mitsukuni
    Shinozaki, Eiji
    Chin, Keisho
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [7] Immunological impact of ramucirumab on tumor microenvironment in advanced gastric cancer.
    Togashi, Yosuke
    Tada, Yasuko
    Kotani, Daisuke
    Kawazoe, Akihito
    Doi, Toshihiko
    Nishikawa, Hiroyoshi
    Shitara, Kohei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [8] CA125 kinetics as a potential biomarker for ascites progression during taxane plus ramucirumab therapy in patients with advanced gastric cancer.
    Ueda, Akira
    Yuki, Satoshi
    Ando, Takayuki
    Motoo, Iori
    Ito, Ken
    Kito, Yosuke
    Sakumura, Miho
    Ueda, Yuko
    Kajiura, Shinya
    Nakada, Naokatsu
    Nakajima, Koji
    Hosokawa, Ayumu
    Harada, Kazuaki
    Kawamoto, Yasuyuki
    Komatsu, Yoshito
    Yasuda, Ichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 437 - 437
  • [9] Paclitaxel combined with ramucirumab as the second-line chemotherapy for elderly patients with advanced gastric cancer.
    Kusumoto, Tetsuya
    Uehara, Hideo
    Hashimoto, Kenkichi
    Fujinaka, Yoshihiko
    Yoshinaga, Keiji
    Kusumoto, Eiji
    Shinzato, Chiaki
    Sakaguchi, Yoshihisa
    Ikejiri, Koji
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
    Natsume, Makoto
    Shimura, Takaya
    Iwasaki, Hiroyasu
    Okuda, Yusuke
    Kitagawa, Mika
    Okamoto, Yasuyuki
    Hayashi, Kazuki
    Kataoka, Hiromi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (06) : 1037 - 1046
12345